/Join_Us.gif)
/Medicon_Valley_2016.jpg)
/Morrison_Foerster.gif)
/Clinical_trial_470_x_80_(new).gif)
Clinical Trials Update provides you with latest news about clinical trials conducted by MVA member companies. The update gives insight to progress in studies, results and possible indications.
Read the latest update below or use the calendar in the bottom of the page to gain insight into previous results from clinical trials in Medicon Valley.
Latest Clinical Trials Update
Headline Results of Flurizan® in Clinical Phase III Trial
30 June - Myriad Genetics, Inc. has today announced the outcome of a clinical phase III trial of Flurizan® (tarenflurbil) in 1,684 patients with mild Alzheimer's disease. The clinical phase III data do not correspond to the data observed in clinical phase II in patients with mild Alzheimer's disease. Lundbeck and Myriad will now investigate the data further to understand the outcome of the trial in which the compound did not meet the two primary endpoints.
Clinical Trials Update in 2008
Use the calendar to read previous issues of Clinical Trials Update.
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec |
|
1 |
28 |
32 |
36 |
41 |
45 |
49 |
|||||
|
11 |
29 |
33 |
37 |
42 |
46 |
50 |
|||||
|
21 |
30 |
34 |
38 |
43 |
47 |
51 |
|||||
|
13 |
26 |
31 |
35 |
39 |
44 |
48 |
52 |
||||
|
5 |
|
|
|
27 |
|
|
40 |
|
|
|
/Anne_Katrine.gif)